Zvi Y. Fuks

Q: What Schools Are Affiliated With Zvi Y. Fuks

Zvi Y. Fuks is affiliated with the following schools: Stanford University, Cornell University

Zvi Y. Fuks's AcademicInfluence.com Rankings

Zvi Y. Fuks

Physics

#6570

World Rank

#8533

Historical Rank

physics Degrees

Download Badge

Physics

Zvi Y. Fuks's Degrees

PhD Physics Moscow State University

Why Is Zvi Y. Fuks Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Zvi Y. Fuks's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. (2000) (946)
High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. (2002) (831)
High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. (2001) (726)
Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. (1999) (622)
DOSE ESCALATION WITH THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY AFFECTS THE OUTCOME IN PROSTATE CANCER (1998) (616)
Non‐hodgkin's lymphomas iv. clinicopathologic correlation in 405 cases (1973) (578)
Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. (2000) (565)
High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. (2008) (498)
The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. (1991) (448)
The deep inspiration breath-hold technique in the treatment of inoperable non-small-cell lung cancer. (2000) (403)
Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation. (1996) (387)
Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. (1999) (379)
Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. (2001) (356)
Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. (2000) (328)
Long term tolerance of high dose three‐dimensional conformal radiotherapy in patients with localized prostate carcinoma (1999) (327)
Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. (2008) (325)
Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. (1997) (321)
Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. (2010) (299)
Clinically relevant optimization of 3-D conformal treatments. (1992) (297)
Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. (2008) (284)
The role of postoperative radiotherapy after resection of single brain metastases. (1989) (270)
Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. (1999) (248)
Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease. (1976) (246)
The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. (1991) (231)
Comparison of the 5-Year Outcome and Morbidity of Three-Dimensional Conformal Radiotherapy Versus Transperineal Permanent Iodine-125 Implantation for Early-Stage Prostatic Cancer (1999) (216)
Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. (1997) (207)
Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. (1997) (206)
Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer. (2003) (203)
Electron-beam therapy for mycosis fungoides: the Stanford University experience. (1979) (199)
Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. (2012) (192)
A comprehensive three-dimensional radiation treatment planning system. (1988) (191)
Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy. (1994) (178)
Prognostic signs and the management of the mycosis fungoides (1973) (172)
Measurement of patient positioning errors in three-dimensional conformal radiotherapy of the prostate. (1997) (170)
Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. (2003) (165)
Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. (2005) (163)
Intensity-modulated radiotherapy. (2002) (154)
Long‐term effects of external radiation on the pituitary and thyroid glands (1976) (153)
Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas. (1973) (149)
The treatment of single brain metastasis from non‐oat cell lung: Carcinoma surgery and radiation. Versus radiation therapy alone (1986) (147)
The biological basis for conformal three-dimensional radiation therapy. (1991) (143)
Three-dimensional conformal radiation therapy may improve the therapeutic ratio of high dose radiation therapy for lung cancer. (1993) (138)
Non‐Hodgkin's lymphomas. V. Results of radiotherapy (1973) (138)
Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancer. (2008) (135)
Intensity-modulated radiation therapy for prostate cancer. (2002) (134)
Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease (1975) (134)
A method of incorporating organ motion uncertainties into three-dimensional conformal treatment plans. (1996) (134)
Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx. (1991) (132)
Treatment-related symptoms during the first year following transperineal 125I prostate implantation. (1994) (129)
The use of a multi-leaf collimator for conformal radiotherapy of carcinomas of the prostate and nasopharynx. (1993) (128)
Optimization of intensity-modulated 3D conformal treatment plans based on biological indices. (1995) (123)
Staging laparotomies in unselected previously untreated patients with non‐Hodgkin's lymphomas (1973) (122)
Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease. (1993) (121)
The potential and limitations of the inverse radiotherapy technique. (1994) (120)
IMRT of large fields: whole-abdomen irradiation. (2001) (118)
Three-dimensional conformal radiation therapy in localized carcinoma of the prostate: interim report of a phase 1 dose-escalation study. (1994) (117)
The effect of setup uncertainties on the treatment of nasopharynx cancer. (1993) (116)
Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test. (1976) (116)
Clinical staging for cutaneous T-cell lymphoma. (1984) (112)
Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer. (2005) (108)
Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma. (1994) (106)
The rationale for curative radiotherapy in mycosis fungoides. (1977) (105)
Predictors of local control after single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases. (2011) (103)
Short-term freedom from disease progression after I-125 prostate implantation. (1994) (98)
Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. (1995) (97)
The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate. (1994) (96)
Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer. (2002) (94)
Adjuvant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy after radiation therapy in stage I low‐grade and intermediate‐grade non‐Hodgkin lymphoma. Results of a prospective randomized study (1993) (94)
Localized carcinoma of the prostate (Stages T1B, T1C, T2, and T3). Review of management with external beam radiation therapy (1993) (94)
Anterior decompression of the spine for metastatic epidural cord compression: A promising avenue of therapy? (1982) (92)
The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy. (1997) (91)
Radiation therapy in the management of cutaneous T-cell lymphomas. (1979) (91)
From IMRT to IGRT: frontierland or neverland? (2006) (88)
Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data. (2001) (88)
Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer. (2003) (87)
Three-dimensional conformal radiotherapy and dose escalation: where do we stand? (1998) (86)
The coexistence of nodular and diffuse patterns in nodular non‐Hodgkin's lymphomas. Significance and clinicopathologic correlation (1977) (83)
Modeling the development of metastases from primary and locally recurrent tumors: comparison with a clinical data base for prostatic cancer. (1993) (82)
Impact of the time interval between surgery and postoperative radiation therapy on locoregional control in advanced head and neck cancer (1990) (81)
An improved method for computerized tomography-planned transperineal 125iodine prostate implants. (1991) (81)
Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer. (2000) (80)
Total-skin electron treatment of mycosis fungoides. (1971) (80)
The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma. (1995) (79)
Esthesioneuroblastoma: Is there a role for elective neck treatment? (1991) (79)
Computerized design of target margins for treatment uncertainties in conformal radiotherapy. (1999) (74)
Locally advanced prostatic cancer: long-term toxicity outcome after three-dimensional conformal radiation therapy--a dose-escalation study. (1998) (74)
Spinal epidural tumor in patients with prostate cancer. Clinical and radiographic predictors of response to radiation therapy (1992) (67)
The long term effects of radiation on T and B lymphocytes in the peripheral blood after regional irradiation (1977) (66)
Hyperkeratotic and verrucous features of mycosis fungoides. (1977) (65)
Short-term morbidity from CT-planned transperineal I-125 prostate implants. (1993) (63)
Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer. (2000) (63)
Accurate setup of paraspinal patients using a noninvasive patient immobilization cradle and portal imaging. (2005) (61)
Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group. (1979) (57)
Non‐Hodgkin's lymphomas of stage III extent. Is total lymphoid irradiation appropriate treatment? (1976) (56)
A feasibility study of automated inverse treatment planning for cancer of the prostate. (1998) (56)
Current concepts in cancer: ovary--treatment for stages III and IV. The multimodal approach to the treatment of stage III ovarian carcinoma. (1982) (55)
External radiotherapy of ovarian cancer: standard approaches and new frontiers. (1975) (54)
Spinal metastases: From conventional fractionated radiotherapy to single-dose SBRT. (2015) (54)
Abdominal irradiation in non‐Hodgkin's lymphomas (1976) (53)
Chemotherapeutic and surgical induction of pathological complete remission and whole abdominal irradiation for consolidation does not enhance the cure of stage III ovarian carcinoma. (1988) (52)
Three-dimensional photon treatment planning for carcinoma of the nasopharynx. (1991) (52)
Three dimensional conformal treatment planning with multileaf collimators. (1995) (51)
Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancer. (2002) (51)
Fluoroscopic visualization of the prostatic urethra to guide transperineal prostate implantation. (1994) (50)
125iodine reimplantation for locally progressive prostatic carcinoma. (1990) (50)
Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera. (1976) (48)
Variation in prostate position: Quantitation and implications for three-dimensional conformal radiation therapy (1993) (48)
Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. (1999) (46)
Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy. (2003) (46)
Patterns of presentation and relapse in the non-Hodgkin's lymphomata. (1975) (45)
The treatment of mycosis fungoides. Adjuvant topical mechlorethamine after electron beam therapy (1977) (45)
Reduced incidence of the somnolence syndrome in leukemic children with steroid coverage during prophylactic cranial radiation therapy. Results of a pilot study (1989) (44)
Three-dimensional conformal treatment: a new frontier in radiation therapy. (1991) (43)
The role of radiation therapy in the control of pain from pancreatic carcinoma. (1988) (42)
A study of the effects of internal organ motion on dose escalation in conformal prostate treatments. (2003) (41)
Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability models. (2000) (40)
Mechlorethamine desensitization in therapy for mycosis fungoides. Topical desensitization to mechlorethamine (nitrogen mustard) contact hypersensitivity. (1975) (39)
The role of lymphography in patients with ovarian cancer (1974) (38)
Phase III Multi-Center, Prospective, Randomized Trial Comparing Single Dose 24 Gy Radiotherapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer. (2021) (37)
Timing of lethality from gastrointestinal syndrome in mice revisited. (2009) (37)
The rationale for curative radiotherapy for ovarian carcinoma. (1975) (36)
Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease. (1989) (34)
Image-fusion of MR spectroscopic images for treatment planning of gliomas. (2004) (33)
Successful chemotherapy of recurrent intracranial germinoma with spinal metastases (1983) (31)
A reappraisal of the role of prophylactic cranial irradiation in limited small cell lung cancer. (1992) (31)
Education and Training for Radiation Scientists: Radiation Research Program and American Society of Therapeutic Radiology and Oncology Workshop, Bethesda, Maryland, May 12–14, 2003 (2003) (30)
Phenotype-Oriented Ablation of Oligometastatic Cancer with Single Dose Radiation Therapy. (2019) (30)
Acute myocardial infarction with normal coronary arteriogram after mantle field radiation therapy for Hodgkin's disease (1983) (30)
Prognostic signs and the management of the mycosis fungoides. (1973) (30)
Safety and Efficacy of Virtual Prostatectomy With Single-Dose Radiotherapy in Patients With Intermediate-Risk Prostate Cancer: Results From the PROSINT Phase 2 Randomized Clinical Trial. (2021) (28)
Phase I dose escalation study using the deep inspiration breath hold technique to safely increase dose to 81 Gy in the treatment of inoperable non-small cell lung cancer (2000) (28)
Preliminary results of alternating combination chemotherapy (CT) and hyperfractionated radiotherapy (HART) in advanced rhabdomyosarcoma (RMS). (1988) (28)
Initial clinical experience with computer-controlled conformal radiotherapy of the prostate using a 50-MeV medical microtron. (1994) (28)
Topical mechlorethamine therapy for mycosis fungoides (1977) (27)
Lymphography in mycosis fungoides (1974) (26)
New wine in an old bottle? Dose escalation under dose-volume constraints: a model of conformal therapy of the prostate. (1996) (26)
Definitive irradiation for localized non-Hodgkin's lymphoma of breast. (1989) (25)
Results of a phase I dose escalation study in the treatment of inoperable non-small cell lung cancer (2003) (25)
Beam characteristics of a new generation 50 MeV racetrack microtron. (1995) (25)
Clinical and technical aspects of conformal therapy (1993) (24)
Delayed central nervous system (cns) radiation in childhood cns acute lymphoblastic leukemia results of a pilot trial (1990) (23)
Results of postoperative megavoltage radiotherapy of malignant surface epithelial tumors of the ovary. (1975) (23)
Three-dimensional treatment planning considerations for prostate cancer. (1991) (22)
Megavoltage radiotherapy using water bolus in the treatment of Kaposi's sarcoma. (1986) (20)
The potential and limitations of the inverse radiotherapy technique (1995) (20)
Experience with lymphography in patients with mycosis fungoides. (1979) (19)
Early observations of acute and chronic toxicity & psa response in patients with carcinoma of the prostate treated on a dose escalation study with 3D-CRT (1994) (19)
Fractionated radiation facilitates repair and functional motor recovery after spinal cord transection in rat (2001) (19)
3-D conformal radiotherapy for carcinoma of the prostate. Clinical experience at the Memorial Sloan-Kettering Cancer Center. (1996) (19)
Conformal three dimensional treatment planning may improve the therapeutic ratio of high dose radiation therapy for lung cancer (1991) (19)
Combined modality treatment for stage III ovarian carcinoma. (1985) (18)
Comparison of kilovoltage cone-beam computed tomography with megavoltage projection pairs for paraspinal radiosurgery patient alignment and position verification. (2008) (17)
3-D conformal radiation therapy for non-small cell lung carcinoma. Clinical experience at the Memorial Sloan-Kettering Cancer Center. (1996) (17)
Diaphragmatic treatment in ovarian carcinoma: a new radiotherapeutic technique. (1977) (16)
Ten-year results of dose escalation with 3-dimensional conformal radiotherapy for patients with clinically localized prostate cancer (2003) (16)
Interstitial Irradiation in Prostatic Cancer: Report of 10-Year Results (1987) (16)
E-rosette inhibiting substance in Hodgkin's disease spleen extracts. (1977) (16)
1008 Correlation of DVH and treatment planning variables with late rectal bleeding after 3D-CRT of prostate cancer: What is the best way to define the rectal length and volume? (1999) (15)
Improved survival of poor prognosis diffuse histiocytic (large cell) lymphoma managed with sequential induction chemotherapy, "boost" radiation therapy, and autologous bone marrow transplantation. (1988) (15)
Twice daily thoracic irradiation for limited small cell lung cancer. (1991) (14)
Conformal radiation treatment: a critical appraisal. (1995) (14)
Radiographic manifestations of carcinoma of the cervix and complications of its treatment. (1974) (13)
Serum transcobalamin II levels in breast carcinoma patients. (1981) (13)
Local control is associated with decreased distant failure in early stage carcinoma of the prostate (1989) (13)
Tumor control probability for permanent implants in prostate. (1993) (13)
Conjecture on the use of high energy electrons for conformal radiotherapy (1992) (13)
Roentgenologic aspects of Hodgkin's disease: repeat lymphangiography. (1973) (13)
Target motion mitigation promotes high-precision treatment planning and delivery of extreme hypofractionated prostate cancer radiotherapy: Results from a phase II study. (2020) (12)
Sex hormone binding globulin (SHBG) in breast cancer: a correlation with obesity but not with estrogen receptor status. (1984) (12)
An Analysis of Prognostic Factors for Local Control of Malignant Spine Tumors Treated with Spine Radiosurgery (2011) (11)
Long-Term Implications of a Positive Posttreatment Biopsy in Patients Treated with External Beam Radiotherapy for Clinically Localized Prostate Cancer (2019) (11)
Direct fluorometric determination of erythrocyte free and zinc protoporphyrins in health and disease. (1985) (10)
16 : Long-Term Distant Metastases-Free Survival and Cause-Specific Survival Outcomes After High Dose Conformal Radiotherapy for Clinically Localized Prostate Cancer (2006) (10)
Observations on the natural history and treatment of recurrent major salivary gland cancer (1990) (10)
The role of radiation therapy in the management of ovarian carcinoma. (1977) (10)
The use of port films from multiple projections to determine the spatial distribution of setup errors for prostate cancer patients (1994) (10)
Is cranial radiation necessary for CNS prophylaxis in pediatric NHL? (1987) (10)
Roentgenologic Aspects of Hodgkin's Disease: (1973) (10)
Acute morbidity and PSA response in patients with carcinoma of the prostate treated with three dimensional conformal radiation therapy (1992) (10)
59 : Intensity Modulated Radiation Therapy to a Dose of 86.4 Gy for Localized Prostate Cancer: Toxicity Data and Preliminary Biochemical Outcomes (2006) (9)
The evolving role of external beam radiotherapy in localized prostate cancer. (2019) (9)
Impact of Transurethral Resection on the Long-Term Outcome of Patients with Prostatic Carcinoma (1993) (9)
The Impact of Local Tumor Control on the Outcome in Human Cancer (1993) (9)
112 The deep inspiration breath[ hold technique for the treatment of lung cancer: The first 200 treatments (1999) (9)
Initial clinical experience with computer-controlled conformal radiotherapy using the MM50 microtron (1993) (9)
The role of total skin irradiation with electrons in the management of mycosis fungoides. (1977) (9)
Final report of the 70.2 GY and 75.6 GY dose levels of a phase I dose escalation study using three dimensional conformal radiotherapy in the treatment of inoperable lung cancer (1998) (9)
Poster ViewingAcute Toxicity Following Single-Dose Radiation Therapy in the Management of Intermediate Risk Prostate Cancer: Results from a Phase 2 Randomized Trial (2017) (8)
[Small-cell lung cancer]. (1984) (8)
76 Impact of radiation dose on achieving nadir PSA levels after 3-dimensional conformal radiotherapy for patients with localized prostate cancer (1996) (8)
Rectal bleeding after conformal radiotherapy of prostate cancer and dose volume histograms (1998) (8)
Conformal Avoidance of Normal Organs at Risk by Perfusion Modulated Dose Sculpting in Tumor Single Dose Radiotherapy. (2020) (8)
Inclusion of systematic setup uncertainties in treatment plans (1994) (8)
Incorporation of organ motion uncertainties into 3d prostate treatment plans (1994) (7)
Repeat Lymphography in Non-Hodgkin's Lymphoma. (1975) (7)
The effects of ionizing irradiation on production of thromboxane and prostacyclin by the isolated perfused rat kidney. (1988) (7)
78 The potential of optimized intensity modulation to escalate prostate dose to 86.4 GY (1996) (7)
Single-dose radiotherapy (SDRT) in the management of intermediate risk prostate cancer: Early results from a phase II randomized trial. (2018) (7)
Clinical characteristics of patients with epidermoid carcinoma of the upper aerodigestive tract who develop second malignant tumors. (1992) (7)
A new device to stabilize templates for transperineal I-125 implants. (1991) (7)
Reproducibility and accuracy of a target motion mitigation technique for dose-escalated prostate stereotactic body radiotherapy. (2021) (6)
Radiation therapy for locally advanced breast cancer: prognostic factors and complication rate. (1990) (6)
The effect of postoperative radiotherapy on the feasibility of optimal dose adjuvant CMF chemotherapy in stage II breast carcinoma. (1983) (6)
The current role of radiotherapy in the management of ovarian cancer. (1992) (5)
Long-term outcome of high dose intensity modulated radiotherapy for clinically localized prostate cancer (2004) (5)
Cerebral necrosis following neutron radiation of an extracranial tumor (1988) (5)
Thromboxane and Prostacyclin Production by Irradiated and Perfused Rat Kidney (1987) (5)
Single Fraction Image Guided Intensity Modulated Radiation Therapy (IG IMRT) for Metastatic Lesions of the Spinal Column (2005) (5)
SECTION 4 Cancer of the Prostate (2005) (5)
Phase III Multi-Center, Prospective Randomized Trial Comparing High Dose Single Fraction Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Human Cancer (2018) (4)
29 Mixed modality intensity-modulated radiation therapy treatment planning for intracranial lesions (1997) (4)
Elevation of erythrocyte zinc- and free protoporphyrins with metastatic spread in cancer patients. (1986) (4)
Forging New Strategies in the Cure of Human Oligometastatic Cancer. (2020) (4)
PSA response after transperineal I-125 prostate implantation (1993) (4)
46 Improved conformality and reduced toxicity with high-dose intensity modulated radiation therapy (IMRT) for patients with prostate cancer (1999) (4)
Correlation of long-term biochemical outcome with post-treatment biopsy results for patients treated with 3-dimensional conformal radiotherapy for prostate cancer (2004) (3)
1043 Dose escalation for maxillary sinus cancer using intensity-modulated radiation therapy (IMRT) (1997) (3)
NEW CONCEPTS IN THE MANAGEMENT OF MYCOSIS FUNGOIDES (1974) (3)
Post-treatment F-18 FDG-PET Standardized Uptake Value (SUV) Predicts Local Control Following High- dose Single-fraction IGRT (2009) (3)
Advances in translational radiation oncology: from molecular signaling to cancer cure. (2004) (3)
Predicting the metastatic potential of prostatic cancer: Is lymph node staging necessary? (1987) (3)
50 – Cancer of the Ovary (2010) (3)
Serum transcobalamin levels as an early indicator of bone marrow engraftment following transplantation (1983) (2)
Three-dimensional conformal radiation therapy: recent developments and prospects for the future. (1995) (2)
Incorporation of multileaf collimation in clinical 3D conformal treatment planning (1992) (2)
Outcome of clinical stage T1c prostate cancer treated with 3-dimensional conformal radiotherapy (1998) (2)
Short-term results of computerized tomographic-based transperineal iodine-125 prostate implantation (1993) (2)
Does local-regional control affect distant metastatic spread in squamous cell carcinoma of the head and neck? Results of an rtog analysis. (1990) (2)
Predictors o f B iochemical O utcome W ith S alvage C onformal Radiotherapy A fter R adical P rostatectomy f or P rostate C ancer (2003) (2)
Risk stratification predicts biochemical outcome after salvage post-prostatectomy three-dimensional conformal radiation therapy (2001) (2)
Predictors of post-treatment prostatic biopsy outcome after 3-dimensional conformal radiotherapy for patients with clinically localized prostate cancer (2000) (2)
Urethra Sparing With Target Motion Mitigation in Dose-Escalated Extreme Hypofractionated Prostate Cancer Radiotherapy: 7-Year Results From a Phase II Study (2022) (2)
Early PSA density kinetics predicts biochemical and local failure following extreme hypofractionated radiotherapy in intermediate-risk prostate cancer. (2022) (1)
New concepts in the management of mycosis fungoides. (1974) (1)
Prognostic factors for maintained efficacy of Sildenafil citrate in the management of erectile dysfunction after radiotherapy for prostate cancer (2003) (1)
Computer-Controlled 3D Conformal Radiation Therapy (1995) (1)
Prognostic significance of changes in serum transcobalamin levels in cancer patients with chemotherapy-induced granulocytopenia. (1983) (1)
Diagnosis and Treatment of Mycosis Fungoides (1974) (1)
Tantalum, a new contrast agent for tracheobronchography. (1974) (1)
PO-0927: Minimizing intra-fractional prostate motion during hypofractionated radiotherapy using beacon transponders (2015) (1)
Phase I study of the combination of iv mitomycin and oral metronidazole. (1984) (1)
CLINICAL UROLOGY: Letters to the EditorRE: HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED CANCER (2001) (1)
1012 Quantification of variation in organ position and volume during conformal radiotherapy of the prostate (1996) (1)
100 Risk factors for impotence in patients with carcinoma of the prostate treated with three-dimensional conformal radiation therapy (1995) (1)
124 Planning, delivery, and quality assurance of treatment with dynamic multileaf collimator for prostate: A strategy for large scale implementation (1996) (1)
Questioning current policies for the curative management of ovarian carcinoma. (1988) (1)
IMPROVED OUTCOME WITH HIGH DOSE 3-DIMENSIONAL CONFORMAL RADIOTHERAPY: RESULTS OF 1050 PATIENTS TREATED FOR LOCALIZED PROSTATE CANCER (1999) (1)
PV-0621: Single-Dose SBRT for Intermediate-risk prostate cancer: Early results from a randomized trial (2018) (1)
Pitfalls in deducing radiobiological parameters for tumors from clinical data: a study of biopsy outcome after three-dimensional conformal radiation therapy (3D-CRT) of prostate cancer☆ (2000) (1)
Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and distant therapy (1992) (1)
Early Posttreatment PET SUVmax Predicts Local Control Following Single Dose Radiation Therapy (SDRT) in Oligometastasis (2015) (1)
[A marihuana component for nausea and vomiting induced by chemo- and radiotherapy]. (1983) (1)
PO-0844 Target motion mitigation and dose painting in prostate cancer SBRT: results from a Phase II study (2019) (1)
Preliminary results of alternating intensive multiagent chemotherapy (CT) and hyperfractionated radiotherapy (hart) in advanced rhabdomyosarcoma (rms): the memorial hospital (MSKCC) experience (1987) (1)
173 Single fraction image guided intensity modulated radiotherapy for paraspinal metastases (2006) (0)
325Conformal therapy of prostate cancer using intensity-modulated x-rays designed by the inverse technique and produced with dynamic multileaf collimation (1996) (0)
Sphingolipid Signaling With High Single-Dose SBRT/SRS (2014) (0)
An in vivo tissue-model of mitotic cell death and EGFR-signaling (2003) (0)
Radiation therapy in carcinoma of the ovary: Indications, technical considerations and results z (1987) (0)
Treatment of febrile granuloycytopenic cancer patients receiving antineoplastic therapy with a combination of carbenicillin, cefazolin and gentamicin. (1983) (0)
Single-Dose vs 5-Fraction SBRT For Intermediate-Risk Prostate Cancer: 4-Year Results From A Randomized Trial (2020) (0)
[Treatment of chondrosarcomas of the extremities with isolated perfusion of radioactive S35]. (1967) (0)
Positron Emission Tomography−Derived Metrics Predict the Probability of Local Relapse After Oligometastasis-Directed Ablative Radiation Therapy (2022) (0)
Letter: Diagnosis and treatment of mycosis fungoides. (1974) (0)
Pretreatment N omogram f or P redicting t he O utcome of T hree-Dimensiona l C onformal R adiotherapy i n Prostate C ancer (2000) (0)
Book review (2004) (0)
Continuous course of megavoltage radiotherapy for carcinoma of the prostate. (1988) (0)
Predictors of late femoral head toxicity after high-dose 3D-conformal radiotherapy and intensity modulated radiotherapy (2002) (0)
In Reply to Rans et al. (2021) (0)
A study of the effects of internal organ motion and setup error on dose escalation in conformal prostate treatments (1998) (0)
Health-related quality of life of salvage prostate reirradiation using stereotactic ablative radiotherapy with urethral-sparing (2022) (0)
Treatment of Febrile Granulocytopenic Cancer Patients Receiving Antineoplastic Therapy With a Combination of Carbenicillin, Cefazolin and Gentamycin (1984) (0)
The Biology of Single Dose Radiotherapy (2016) (0)
Total dose of twice daily thoracic irradiation and the use of concomitant chemotherapy may be important determinants of outcome for limited stage small-cell lung cancer (1990) (0)
2136 Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostatic adenocarcinoma (1999) (0)
Induction chemotherapy with cisplatin and cyclophosphamide and maintenance chemotherapy with doxorubicin and 5-FU in advanced urinary bladder tumors. (1983) (0)
Morbidity of permanent I-126 transperineal prostate implantation (1993) (0)
Correlation of PSA with long term outcome in patients treated for prostatic carcinoma (1993) (0)
Single-Dose Radiotherapy for Prostate Cancer-Lessons Learned From Single-Fraction High-Dose-Rate Brachytherapy-Reply. (2021) (0)
Combined modality therapy for advanced stage hodgkin's disease: patterns of relapse, prognostic factors and the role of radiation therapy (1990) (0)
322Clinical implementation of dynamic multileaf-modulation for intensity-modulated treatments (1996) (0)
Using logical combinations of structures as a utility for inverse planning (1998) (0)
Pre-Treatment and Early Post-Radiotherapy PET Metabolic Metrics Predict Probability of Local Relapse in Oligometastases (2019) (0)
EP-1295: Target motion assessment with beacon transponders during extreme hypofractionated IGRT of the prostate (2014) (0)
[Intraoperative irradiation for abdominal tumors]. (1984) (0)
Phase II Prospective Trial to Assess the Feasibility and Efficacy of Dynamic 24Gy Single Dose Ablative Stereotactic Radiation Therapy in Oligometastatic Human Cancer (2018) (0)
125 A Monte Carlo approach to the design of target margins for setup errors and organ motion in conformal radiotherapy (1996) (0)
Adjubant chop chemotherapy following radiotherapy in stage I low and intermediate grade non-hodgkin's lymphoma: Results of a prospective randomized study (1991) (0)
29 A new era in radiotherapy (1995) (0)
2132 Analysis of biopsy outcome after three-dimensional radiation therapy of prostate cancer using dose distribution variables (1999) (0)
Conformal radiotherapy for prostate cancer (1999) (0)
Abrogation of acute and chronic gvhd in adults with aplastic anemia aa treated with t cell depleted marrow transplants (1990) (0)
Clinical Use of Anchored Electromagnetic Beacon Transponder Tracking During SBRT of Lung Lesions (2015) (0)
Comparison o f t he 5 -Year O utcome a nd M orbidity of T hree-Dimensiona l C onformal R adiotherapy Versus T ransperineal P ermanent I odine-125 I mplantation for E arly-Stage P rostatic C ancer (1999) (0)
Phase 1/2 Study of Urethral and Rectal Sparing Following Extreme Hypofractionated (5x9 Gy) Stereotactic Body Radiation Therapy in Prostate Cancer (2016) (0)
PET-derived Metrics Predict the Probability of Local Relapse After Oligometastasis-Directed Ablative Radiotherapy (2021) (0)
[Combined chemotherapy in metastatic breast cancer: predictive value of dose levels and performance status]. (1986) (0)
119 Use of radiobiological indices to guide dose escalation of the prostate cancer patients (1997) (0)
DTIC and Actinomycin D with and without C. Parvum Immunotherapy in Advanced Malignant Melanoma (1981) (0)
Signaling-based apoptosis therapy: Potential for improving the outcome in clinical radiotherapy (1996) (0)
Treatment of locally advanced breast carcinoma with high-dose external beam supervoltage radiotherapy. (1981) (0)
Will an enhanced local control with conformal radiation therapy lead to improved treatment outcome (1993) (0)
Modeling the Development of MÃ©tastasesfrom Primary and Locally Recurrent l\imors: Comparison with a Clinical Data Base for Prostatic Cancer1 (2006) (0)
Chapter 6 – Three-Dimensional and Conformal Treatment Planning (2002) (0)
Pretreatment N omogram T hat P redicts 5 -Year P robability o f Metastasis F ollowing T hree-Dimensiona l C onformal R adiation Therapy f or L ocalized P rostate C ancer (2003) (0)
1048 Parotid gland sparing using inverse planning for radiotherapy of nasopharyngeal carcinomas (1997) (0)
Total lymphoid irradiation and high-dose chemotherapy followed by autologous bone marrow transplantation for relapsed or refractory Hodgkin's disease: 7-year experience (1992) (0)
The Impact of Dose upon the Local Control of Solid Tumor Metastases Treated with High-dose Spine Radiosurgery (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Zvi Y. Fuks?

Zvi Y. Fuks is affiliated with the following schools: